prof. dr. E. (Eelko) Hak

Full professor of Clinical Pharmacoepidemiology/Educational director Pharmacy-MPS

prof. dr. E. (Eelko) Hak
Telephone:
+31 50 36 38707 (Direct)
+31 50 36 37576 (Secretariat)
E-mail:
e.hak rug.nl

Research

Postal address:
A Deusinglaan1
Gebouw 3214, ruimte 0457
9713 AV
Groningen
Netherlands
Phone: +31 50 363 8707
  1. 2016
  2. Bakker, A. M. C., Hak, E., Bos, H., & Schuiling-Veninga, C. C. M. (2016). Fertility treatment and the risk of cardiovascular diseases in the offspring. Abstract from 32st ICPE International Conference on Pharmacoepidemiology, Dublin, Ireland. https://doi.org/10.1002/pds.4070
  3. Azim, S., Hak, E., Bos, H., & Schuiling-Veninga, C. C. M. (2016). Atopic diseases and the risk of developing ulcerative colitis. Abstract from 32st ICPE International Conference on Pharmacoepidemiology, Dublin, Ireland.
  4. 2015
  5. Berm, E. J. J., Hak, E., Postma, M., Boshuisen, M., Breuning, L., Brouwers, J. R. B. J., Dhondt, T., Jansen, P. A. F., Kok, R. M., Maring, J. G., van Marum, R., Mulder, H., Oude Voshaar, R., Risselada, A. J., Venema, H., Vleugel, L., & Wilffert, B. (2015). Effects and cost-effectiveness of pharmacogenetic screening for CYP2D6 among older adults starting therapy with nortriptyline or venlafaxine: study protocol for a pragmatic randomized controlled trial (CYSCEtrial). TRIALS, 16(1), [37]. https://doi.org/10.1186/s13063-015-0561-0
  6. Rondy, M., Launay, O., Puig-Barbera, J., Gefenaite, G., Castilla, J., Donati, K. D. G., Galtier, F., Hak, E., Guevara, M., Costanzo, S., Moren, A., & European Hosp IVE Network (2015). 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: Estimates from a European network of hospitals. Eurosurveillance, 20(2). http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=21011
  7. 2014

ID: 347541